Skip to main content

Table 3 Patient Demographic and Hyperhidrosis History Data From Phase 2 and Phase 3 Trials

From: Development and validation of the Axillary Sweating Daily Diary: a patient-reported outcome measure to assess axillary sweating severity

Characteristic

Phase 2:

DRM04-HH02 (N = 105)

Phase 3 Pooled:

ATMOS-1 & ATMOS-2

Age − 9-15 Years (N = 32)

Age ≥ 16 Years (N = 665)

Age (years), mean ± SD

33.3 ± 11.7

32.7 ± 11.4

13.8 ± 1.37

33.6 ± 10.9

Axillary hyperhidrosis history (years), mean ± SD

NA

15.5 ± 10.8

3.4 ± 2.77

16.1 ± 10.7

Female, n (%)

48 (45.7)

371 (53.2)

27 (84.4%)

344 (51.7)

White, n (%)

91 (86.7)

570 (81.8)

26 (81.3%)

544 (81.8)

Weekly Impact Items, n (%) responding Yes to each statement

 Change shirt during the day

79 (75.2%)

N/A

517 (77.7%)

 Take more than 1 shower or bath during the day

58 (55.2%)

N/A

345 (51.9%)

 Feel less confident

84 (80.0%)

N/A

551 (82.9%)

 Feel embarrassed

88 (83.8%)

N/A

583 (87.7%)

 Avoid interactions with others

51 (48.6%)

N/A

402 (60.5%)

Prevent from doing activities

43 (41.0%)

N/A

352 (52.9%)

Weekly Impact Summary,a mean ± SD

3.8 ± 1.90

N/A

4.1 ± 1.90

  1. N/A Not available, data not collected during the study course, SD Standard deviation
  2. aSummary score is derived by assigning a score of 1 for each “Yes” response (range 0 to 6). Validity of the Weekly Impact Summary score has not been tested via dimensionality analyses and should be considered exploratory at this stage